These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 9462978)

  • 1. [A longitudinal study of the course of Alzheimer type dementia].
    Tellería-Díaz JA; Roselló-Silva H; Gómez-Viera N
    Rev Neurol; 1997 Oct; 25(146):1551-6. PubMed ID: 9462978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.
    Modrego PJ; Ferrández J
    Arch Neurol; 2004 Aug; 61(8):1290-3. PubMed ID: 15313849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
    Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
    J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outcome and cognitive changes of mild cognitive impairment in the elderly: a follow-up study of 47 cases].
    Xiao SF; Xue HB; Li GJ; Li CB; Wu WY; Zhang MY
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1441-6. PubMed ID: 16842692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
    Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
    Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clock drawing test in mild and moderate dementia of the Alzheimer's type: a comparative and correlation study.
    Heinik J; Solomesh I; Shein V; Becker D
    Int J Geriatr Psychiatry; 2002 May; 17(5):480-5. PubMed ID: 11994938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive impairment on neuropsychological tasks in a longitudinal study of preclinical Alzheimer's disease.
    Mickes L; Wixted JT; Fennema-Notestine C; Galasko D; Bondi MW; Thal LJ; Salmon DP
    Neuropsychology; 2007 Nov; 21(6):696-705. PubMed ID: 17983283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rates of progression in mild cognitive impairment].
    Bidzan L; Bidzan M
    Psychiatr Pol; 2004; 38(2):251-62. PubMed ID: 15307291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.
    Estévez-González A; Kulisevsky J; Boltes A; Otermín P; García-Sánchez C
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1021-8. PubMed ID: 14618554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment.
    Tang-Wai DF; Knopman DS; Geda YE; Edland SD; Smith GE; Ivnik RJ; Tangalos EG; Boeve BF; Petersen RC
    Arch Neurol; 2003 Dec; 60(12):1777-81. PubMed ID: 14676056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early diagnosis and the course of Alzheimer's disease].
    Sánchez JL; Sayago AM
    Rev Neurol; 2000 Jan 16-31; 30(2):121-7. PubMed ID: 10730317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The psychopathological symptoms of the preclinical stages of Alzheimer's disease].
    Bidzan L
    Psychiatr Pol; 2001; 35(6):1019-32. PubMed ID: 11877882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.
    Squitti R; Bressi F; Pasqualetti P; Bonomini C; Ghidoni R; Binetti G; Cassetta E; Moffa F; Ventriglia M; Vernieri F; Rossini PM
    Neurology; 2009 Jan; 72(1):50-5. PubMed ID: 19122030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.
    Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sustained attention in the preclinical phase of Alzheimer's disease].
    Estévez-González A; García-Sánchez C; Boltes A; García-Nonell C; Rigau-Ratera E; Otermín P; Gironell A; Kulisevsky J
    Rev Neurol; 2003 May 1-15; 36(9):829-32. PubMed ID: 12717669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.